Skip to main content
Log in

HAND2-AS1 associates with outcomes of acute coronary syndrome and regulates cell viability of vascular endothelial cells

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Objective

Acute coronary syndrome (ACS) is an emergency and severe disorder of the cardiovascular system. This paper assessed the expression of plasma HAND2-AS1 in patients with ACS, researched its diagnostic and prognostic significance, and studied its possible mechanism for participating in ACS.

Methods

The concentration of HAND2-AS1 of 101 included patients with ACS was certified by qRT-PCR and its possible diagnostic function was revealed by the receiver operating characteristic (ROC) curve. All patients were followed up for 6 months after percutaneous coronary intervention (PCI) therapy and Kaplan-Meier (K-M) curve and COX regression analysis was performed to estimate the short-term prognostic value of HAND2-AS1 in ACS. The interrelationship between HAND2-AS1 and Gensini score and endothelial injury was identified via Pearson correlation. The function of HAND2-AS1 on the viability, migration, and apoptosis of human umbilical vein endothelial cells (HUVECs) was estimated by the Cell Counting Kit-8 (CCK-8), Transwell chamber, and flow cytometry.

Results

In ACS patients, the expression of serum HAND2-AS1 was prominently decreased and closely correlated with the Gensini score. The decreased HAND2-AS1 expression was of diagnostic significance. Declined plasma HAND2-AS1 was observed in patients with the major adverse cardio-cerebrovascular event (MACCE) and was an independent risk for the poor prognosis of ACS patients. In the cell model, upregulation of HAND2-AS1 improved cell viability and migration and inhibited cell apoptosis.

Conclusion

HAND2-AS1 was an independent biomarker for the diagnosis and prognosis of ACS. HAND2-AS1 might be involved in ACS development by regulating endothelial damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Bergmark BA, Mathenge N, Lawrence-Wright MB et al (2022) Acute coronary syndromes. Lancet 399:1347–1358. https://doi.org/10.1016/s0140-6736(21)02391-6

    Article  PubMed  PubMed Central  Google Scholar 

  2. Harskamp RE, Fanaroff AC, Zhen SW et al (2022) Recognising acute coronary syndrome. BMJ 377:e069591. https://doi.org/10.1136/bmj-2021-069591

  3. Shirasaki K, Minai K, Kawai M et al (2022) Unique crosstalk between platelet and leukocyte counts during treatment for acute coronary syndrome: A retrospective observational study. Medicine 101:e32439. https://doi.org/10.1097/md.0000000000032439

  4. Fang Y, Cheng X, Peng W et al (2022) Atypical manifestations of acute coronary syndrome - throat discomfort: A multi-center observational study. Front Med 16:651–658. https://doi.org/10.1007/s11684-021-0859-0

    Article  PubMed  Google Scholar 

  5. Zhang LS, Liu SQ, Xie XL et al (2021) An improved networked predictive controller for vascular robot using 5G networks. In: 2021 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, p 4674–4678. https://doi.org/10.1109/embc46164.2021.9630311

  6. Wang B, Jinsong L, Hong Y et al (2022) Effect of cardiac rehabilitation therapy combined with WeChat platform education on patients with unstable angina pectoris after PCI. J Healthc Eng 2022:7253631. https://doi.org/10.1155/2022/7253631

    Article  PubMed  PubMed Central  Google Scholar 

  7. Xu H, Zhang J, Jia H et al (2023) Serum histone deacetylase 4 longitudinal change for estimating major adverse cardiovascular events in acute coronary syndrome patients receiving percutaneous coronary intervention. Ir J Med Sci. https://doi.org/10.1007/s11845-023-03326-5

    Article  PubMed  PubMed Central  Google Scholar 

  8. Balaji Srinivasan S, Sehly A, Jaltotage B et al (2022) Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: A 5-year population-based cohort study. Ir J Med Sci. https://doi.org/10.1007/s11845-022-03171-y

    Article  PubMed  PubMed Central  Google Scholar 

  9. Uchida S, Dimmeler S (2015) Long noncoding RNAs in cardiovascular diseases. Circ Res 116:737–750. https://doi.org/10.1161/circresaha.116.302521

    Article  CAS  PubMed  Google Scholar 

  10. Cao M, Luo H, Li D et al (2022) Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases. Int J Cardiol 353:109–117. https://doi.org/10.1016/j.ijcard.2022.01.070

    Article  PubMed  Google Scholar 

  11. Chen L, Huang Y (2022) High expression of lncRNA PELATON serves as a risk factor for the incidence and prognosis of acute coronary syndrome. Sci Rep 12:8030. https://doi.org/10.1038/s41598-022-11260-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Libby P, Pasterkamp G, Crea F, Jang IK (2019) Reassessing the mechanisms of acute coronary syndromes. Circ Res 124:150–160. https://doi.org/10.1161/circresaha.118.311098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Liu X, Li S, Yang Y et al (2021) The lncRNA ANRIL regulates endothelial dysfunction by targeting the let-7b/TGF-βR1 signalling pathway. J Cell Physiol 236:2058–2069. https://doi.org/10.1002/jcp.29993

    Article  CAS  PubMed  Google Scholar 

  14. Ma L, He S, Li H et al (2022) HAND2-AS1 targeting miR-1208/SIRT1 axis alleviates foam cell formation in atherosclerosis. Int J Cardiol 346:53–61. https://doi.org/10.1016/j.ijcard.2021.11.019

    Article  PubMed  Google Scholar 

  15. Kim M, Kang SH, Kim JR et al (2020) Comparison of shear stress-induced thrombotic and thrombolytic effects among 3 different antithrombotic regimens in patients with acute coronary syndrome. Clin Appl Thromb Hemost 26:1076029620912814. https://doi.org/10.1177/1076029620912814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. 张新超, 于学忠, 陈凤英, 朱华栋 (2019) 急性冠脉综合征急诊快速诊治指南(2019). 临床急诊杂志:10

  17. Rodrigues AF, Rebelo C, Simões S et al (2023) A polymeric nanoparticle formulation for targeted mRNA delivery to fibroblasts. Adv Sci 10:e2205475. https://doi.org/10.1002/advs.202205475

  18. Atwood J (2022) Management of acute coronary syndrome. Emerg Med Clin North Am 40:693–706. https://doi.org/10.1016/j.emc.2022.06.008

    Article  PubMed  Google Scholar 

  19. Shin M, Mun S, Park SH et al (2021) Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach. Biosci Rep 41. https://doi.org/10.1042/bsr20210344

  20. Wang L, Jin Y (2020) Noncoding RNAs as biomarkers for acute coronary syndrome. Biomed Res Int 2020:3298696. https://doi.org/10.1155/2020/3298696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Batra G, Lindbäck J, Becker RC et al (2022) Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes. J Am Coll Cardiol 80:1735–1747. https://doi.org/10.1016/j.jacc.2022.08.767

    Article  CAS  PubMed  Google Scholar 

  22. Li D, Ma Y, Deng W, Feng J (2022) Construction and analysis of lncRNA-associated ceRNA network in atherosclerotic plaque formation. Biomed Res Int 2022:4895611. https://doi.org/10.1155/2022/4895611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bampatsias D, Mavroeidis I, Tual-Chalot S et al (2022) Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease. Thromb Haemost 122:1932–1942. https://doi.org/10.1055/a-1914-2094

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wen C, Li B, Nie L et al (2022) Emerging roles of extracellular vesicle-delivered circular RNAs in atherosclerosis. Front Cell Dev Biol 10:804247. https://doi.org/10.3389/fcell.2022.804247

  25. Gao R, Wang L, Bei Y et al (2021) Long noncoding RNA cardiac physiological hypertrophy-associated regulator induces cardiac physiological hypertrophy and promotes functional recovery after myocardial ischemia-reperfusion injury. Circulation 144:303–317. https://doi.org/10.1161/circulationaha.120.050446

    Article  CAS  PubMed  Google Scholar 

  26. Xue Q, Yang L, Wang J et al (2022) lncRNA ROR and miR-125b predict the prognosis in heart failure combined acute renal failure. Dis Markers 2022:6853939. https://doi.org/10.1155/2022/6853939

  27. Yan L, Zhang Y, Zhang W et al (2020) lncRNA-NRF is a potential biomarker of heart failure after acute myocardial infarction. J Cardiovasc Transl Res 13:1008–1015. https://doi.org/10.1007/s12265-020-10029-0

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zheng PF, Chen LZ, Liu P, Pan HW (2022) A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction. Aging 14:4085–4106. https://doi.org/10.18632/aging.204075

  29. Ateş AH, Arslan U, Aksakal A et al (2018) Plasma chemerin levels are increased in ST elevation myocardial infarction patients with high thrombus burden. Cardiol Res Pract 2018:5812704. https://doi.org/10.1155/2018/5812704

  30. Zhang W, Liu B, Wang Y et al (2022) miR-195–3p/BDNF axis regulates hypoxic injury by targeting P-ERK1/2 expression. Medicine 101:e31586. https://doi.org/10.1097/md.0000000000031586

  31. Sanz-Rubio D, Khalyfa A, Qiao Z et al (2021) Cell-selective altered cargo properties of extracellular vesicles following in vitro exposures to intermittent hypoxia. Int J Mol Sci 22. https://doi.org/10.3390/ijms22115604

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qiumei Cao.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

All individuals signed informed consent, and the study was authorized by the ethics committee of Beijing Tongren Hospital, Capital Medical University.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Xu, R., Cao, Q. et al. HAND2-AS1 associates with outcomes of acute coronary syndrome and regulates cell viability of vascular endothelial cells. Ir J Med Sci 193, 131–138 (2024). https://doi.org/10.1007/s11845-023-03466-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-023-03466-8

Keywords

Navigation